TY - JOUR
T1 - Second Primary Tumors After Primary Brain Tumors and Vice Versa
T2 - A Single-Center, Retrospective Study
AU - Angez, Meher
AU - Tariq, Rabeet
AU - Zafar, Alveena
AU - Ahmed, Ali Azan
AU - Hameed, Ayesha Nasir
AU - Waqar, Usama
AU - Enam, Syed Ather
N1 - Publisher Copyright:
© 2025 The Korean Brain Tumor Society.
PY - 2025/1
Y1 - 2025/1
N2 - Background Advancements in surgery, chemotherapy, and radiotherapy have improved survival for brain tumor patients, increasing the risk of second primary tumors (SPTs) among long-term survivors. This study examines the types and risks of SPTs in brain tumor patients presenting at a tertiary care hospital. Methods This single-center, retrospective study explored occurrences of SPTs following primary brain tumors and occurrences of brain tumors as SPTs following primary extra neural tumors. A total of 41 patients were included and analyzed presenting with histologically confirmed SPTs between 1st January 2000 and 31st December 2020. Results The study included 41 patients with SPTs, primarily female (65.9%). Of these, 20 patients (48.7%) developed SPTs after a primary brain tumor, while 21 patients (51.2%) developed brain tumors as SPTs after extra-neural tumors. Among patients who developed SPTs after brain tumors (n=20), meningioma (n=8, 40.0%) and pituitary adenoma (n=6, 30.0%) were the most prevalent first primary tumors (FPTs) while breast tumors predominated as SPTs (n=4, 20.0%). Survival analysis indicated younger mean age (44.5 years) for patients marked alive, compared to those marked deceased (57.0 years) and those with unknown outcomes (63.0 years). Conclusion Based on this retrospective analysis, the median age at diagnosis was 44.5 years, with a considerable number of patients (36.6%) having uncertain outcomes at follow-up due to incomplete records. These findings highlight the need for improved follow-up data management to better assess long-term survival in patients with SPTs following brain tumors.
AB - Background Advancements in surgery, chemotherapy, and radiotherapy have improved survival for brain tumor patients, increasing the risk of second primary tumors (SPTs) among long-term survivors. This study examines the types and risks of SPTs in brain tumor patients presenting at a tertiary care hospital. Methods This single-center, retrospective study explored occurrences of SPTs following primary brain tumors and occurrences of brain tumors as SPTs following primary extra neural tumors. A total of 41 patients were included and analyzed presenting with histologically confirmed SPTs between 1st January 2000 and 31st December 2020. Results The study included 41 patients with SPTs, primarily female (65.9%). Of these, 20 patients (48.7%) developed SPTs after a primary brain tumor, while 21 patients (51.2%) developed brain tumors as SPTs after extra-neural tumors. Among patients who developed SPTs after brain tumors (n=20), meningioma (n=8, 40.0%) and pituitary adenoma (n=6, 30.0%) were the most prevalent first primary tumors (FPTs) while breast tumors predominated as SPTs (n=4, 20.0%). Survival analysis indicated younger mean age (44.5 years) for patients marked alive, compared to those marked deceased (57.0 years) and those with unknown outcomes (63.0 years). Conclusion Based on this retrospective analysis, the median age at diagnosis was 44.5 years, with a considerable number of patients (36.6%) having uncertain outcomes at follow-up due to incomplete records. These findings highlight the need for improved follow-up data management to better assess long-term survival in patients with SPTs following brain tumors.
KW - Metachronous neoplasms
KW - Second malignancies
KW - Second neoplasms
KW - Second primary neoplasms
UR - https://www.scopus.com/pages/publications/105007612325
U2 - 10.14791/btrt.2024.0041
DO - 10.14791/btrt.2024.0041
M3 - Article
AN - SCOPUS:105007612325
SN - 2288-2405
VL - 13
SP - 17
EP - 22
JO - Brain Tumor Research and Treatment
JF - Brain Tumor Research and Treatment
IS - 1
ER -